1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

@article{Bronowicki20121096A,
  title={1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION},
  author={J. Bronowicki and S. Pol and P. Thuluvath and D. Larrey and C. Martorell and V. Rustgi and D. W. Morris and Z. Younes and M. Fried and M. Bourli{\'e}re and C. H{\'e}zode and R. Reddy and O. Massoud and G. Abrams and V. Ratziu and Bing He and T. Eley and A. Ahmad and A. Thiry and C. Llamoso and P. M{\'e}ndez and E. Hughes},
  journal={Journal of Hepatology},
  year={2012},
  volume={56}
}
16 Citations
Direct-acting antivirals for chronic hepatitis C.
  • 132
  • PDF
An update on the treatment of genotype-1 chronic hepatitis C infection: lessons from recent clinical trials
  • 16
Direct-acting antiviral agents for hepatitis C virus infection.
  • 80
Future therapies for chronic hepatitis C
  • 42
...
1
2
...